Opus Genetics Statistics

Total Valuation

Opus Genetics has a market cap or net worth of $65.63 million. The enterprise value is $33.20 million.

Market Cap	65.63M
Enterprise Value	33.20M

Important Dates

The last earnings date was Wednesday, August 13, 2025, after market close.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Opus Genetics has 59.66 million shares outstanding. The number of shares has increased by 62.36% in one year.

Current Share Class	59.66M
Shares Outstanding	59.66M
Shares Change (YoY)	+62.36%
Shares Change (QoQ)	+87.03%
Owned by Insiders (%)	14.99%
Owned by Institutions (%)	32.91%
Float	30.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.75
Forward PS	4.37
PB Ratio	3.77
P/TBV Ratio	3.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.15
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.90

Current Ratio	1.90
Quick Ratio	1.83
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-27.58

Financial Efficiency

Return on equity (ROE) is -200.57% and return on invested capital (ROIC) is -79.32%.

Return on Equity (ROE)	-200.57%
Return on Assets (ROA)	-55.20%
Return on Invested Capital (ROIC)	-79.32%
Return on Capital Employed (ROCE)	-199.60%
Revenue Per Employee	$856,722
Profits Per Employee	-$3.24M
Employee Count	18
Asset Turnover	0.37
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.53% in the last 52 weeks. The beta is 0.29, so Opus Genetics's price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	-33.53%
50-Day Moving Average	1.06
200-Day Moving Average	1.05
Relative Strength Index (RSI)	50.65
Average Volume (20 Days)	161,844

Short Selling Information

The latest short interest is 255,248, so 0.43% of the outstanding shares have been sold short.

Short Interest	255,248
Short Previous Month	495,953
Short % of Shares Out	0.43%
Short % of Float	0.84%
Short Ratio (days to cover)	3.44

Income Statement

In the last 12 months, Opus Genetics had revenue of $15.42 million and -$58.28 million in losses. Loss per share was -$1.51.

Revenue	15.42M
Gross Profit	-14.57M
Operating Income	-36.87M
Pretax Income	n/a
Net Income	-58.28M
EBITDA	-36.84M
EBIT	-36.87M
Loss Per Share	-$1.51

Full Income Statement

Balance Sheet

The company has $32.43 million in cash and n/a in debt, giving a net cash position of $32.43 million or $0.54 per share.

Cash & Cash Equivalents	32.43M
Total Debt	n/a
Net Cash	32.43M
Net Cash Per Share	$0.54
Equity (Book Value)	17.47M
Book Value Per Share	0.29
Working Capital	18.25M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-31.83M
Capital Expenditures	n/a
Free Cash Flow	-31.83M
FCF Per Share	-$0.53

Full Cash Flow Statement

Margins

Gross Margin	-94.48%
Operating Margin	-239.11%
Pretax Margin	-377.89%
Profit Margin	n/a
EBITDA Margin	-238.89%
EBIT Margin	-239.11%
FCF Margin	n/a

Dividends & Yields

Opus Genetics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-62.36%
Shareholder Yield	-62.36%
Earnings Yield	-88.80%
FCF Yield	-48.50%

Analyst Forecast

The average price target for Opus Genetics is $6.33, which is 475.46% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.33
Price Target Difference	475.46%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	28.37%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1